Skip to content
10-Q

Quarterly Report

ENANTA PHARMACEUTICALS INC ENTA

0001193125-25-179795

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Aug 5, 2025 21.38M sh
Shares Diluted Q3 2025 · Jun 30, 2025 21.38M sh
Shares Diluted Q3 2025 · Jun 30, 2025 21.32M sh
Shares Diluted Q3 2025 · Jun 30, 2024 21.18M sh
Shares Diluted Q3 2025 · Jun 30, 2024 21.15M sh
Capex Q3 2025 · Jun 30, 2025 $11.44M
Capex Q3 2025 · Jun 30, 2024 $9M
Operating Cash Flow Q3 2025 · Jun 30, 2025 −$12.78M
Operating Cash Flow Q3 2025 · Jun 30, 2024 −$68.36M
Cash And Equivalents Q3 2025 · Jun 30, 2025 $44.81M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $37.23M
Stockholders Equity Q3 2025 · Jun 30, 2025 $79.28M
Stockholders Equity Q3 2025 · Mar 31, 2025 $93.54M
Stockholders Equity Q3 2025 · Dec 31, 2024 $111.82M
Stockholders Equity Q3 2025 · Sep 30, 2024 $128.81M
Stockholders Equity Q3 2025 · Jun 30, 2024 $148.92M
Stockholders Equity Q3 2025 · Mar 31, 2024 $166.11M
Stockholders Equity Q3 2025 · Dec 31, 2023 $191.88M
Stockholders Equity Q3 2025 · Sep 30, 2023 $216.74M
Current Liabilities Q3 2025 · Jun 30, 2025 $44.55M
Current Liabilities Q3 2025 · Sep 30, 2024 $57.54M
Total Liabilities Q3 2025 · Jun 30, 2025 $221.75M
Total Liabilities Q3 2025 · Sep 30, 2024 $247.84M
Current Assets Q3 2025 · Jun 30, 2025 $222.71M
Current Assets Q3 2025 · Sep 30, 2024 $299.85M
Total Assets Q3 2025 · Jun 30, 2025 $301.03M
Total Assets Q3 2025 · Sep 30, 2024 $376.65M
Eps Diluted Q3 2025 · Jun 30, 2025 −$0.85
Eps Diluted Q3 2025 · Jun 30, 2025 −$2.96
Eps Diluted Q3 2025 · Jun 30, 2024 −$1.07
Eps Diluted Q3 2025 · Jun 30, 2024 −$4.12
Eps Basic Q3 2025 · Jun 30, 2025 −$0.85
Eps Basic Q3 2025 · Jun 30, 2025 −$2.96
Eps Basic Q3 2025 · Jun 30, 2024 −$1.07
Eps Basic Q3 2025 · Jun 30, 2024 −$4.12
Sga Expense Q3 2025 · Jun 30, 2025 $10M
Sga Expense Q3 2025 · Jun 30, 2025 $34.23M
Sga Expense Q3 2025 · Jun 30, 2024 $13.41M
Sga Expense Q3 2025 · Jun 30, 2024 $44.17M
Rd Expense Q3 2025 · Jun 30, 2025 $27.21M
Rd Expense Q3 2025 · Jun 30, 2025 $82.93M
Rd Expense Q3 2025 · Jun 30, 2024 $28.74M
Rd Expense Q3 2025 · Jun 30, 2024 $100.7M
Net Income Q3 2025 · Jun 30, 2025 −$18.26M
Net Income Q3 2025 · Jun 30, 2025 −$63.19M
Net Income Q3 2025 · Mar 31, 2025 −$22.64M
Net Income Q3 2025 · Dec 31, 2024 −$22.29M
Net Income Q3 2025 · Sep 30, 2024 −$116.05M
Net Income Q3 2025 · Jun 30, 2024 −$22.66M
Net Income Q3 2025 · Jun 30, 2024 −$87.22M
Net Income Q3 2025 · Mar 31, 2024 −$31.16M
Net Income Q3 2025 · Dec 31, 2023 −$33.41M
Operating Income Q3 2025 · Jun 30, 2025 −$18.89M
Operating Income Q3 2025 · Jun 30, 2025 −$66.96M
Operating Income Q3 2025 · Jun 30, 2024 −$24.19M
Operating Income Q3 2025 · Jun 30, 2024 −$91.84M
Revenue Q3 2025 · Jun 30, 2025 $18.31M
Revenue Q3 2025 · Jun 30, 2025 $50.2M
Revenue Q3 2025 · Jun 30, 2024 $17.97M
Revenue Q3 2025 · Jun 30, 2024 $53.03M